InvestorsHub Logo
icon url

JWC3

09/14/22 3:49 PM

#373747 RE: Gator328 #373746

Blind statements!! Completely! Sigma1 has already proven its worth. No erosion will occur!
icon url

powerwalker

09/14/22 4:14 PM

#373754 RE: Gator328 #373746

IMO, Gator, if TGD and Anavex enrolled DPZ-free (or weaned participants of it in a way-out period), then the percentages from the P2b/3 trial should be close to Mayo’s percentages.

As we know from the P2a trial, the 6 (7 through 31 weeks) who were DPZ-naive, demonstrated very strong positive results thru the first 31 and 57 weeks. Those on DPZ did not as they remained on the drug through that time period, as far as we know.

Keep the faith, Everyone.

P.S. Using a laptop, of which, I dislike.
icon url

ignatiusrielly35

09/14/22 4:37 PM

#373756 RE: Gator328 #373746

Yes, but Missling cannot take into consideration the fact that you (and some others) don’t care what happens if AD trial fails because you will exit anyway. He has to take the big picture view. He will need money if that were to happen. Even if it doesn’t fail but another P3 is needed.